United States Cardiovascular Monitoring Devices Market Outlook to 2033 – Resting ECG Machines and Holter Monitors

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4995

GlobalData’s “United States Cardiovascular Monitoring Devices Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Cardiovascular Monitoring Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Resting ECG Machines and Holter Monitoring Systems

The United States Cardiovascular Monitoring Devices Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2024 company share data for Cardiovascular Monitoring Devices Market.
• Global corporate-level profiles of key companies operating within the United States Cardiovascular Monitoring Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Cardiovascular Monitoring Devices is segmented as follows:_x000D_

• Resting ECG Machines_x000D_

• Holter Monitoring Systems

Reasons to Buy

The United States Cardiovascular Monitoring Devices Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Cardiovascular Monitoring Devices Market Segmentation

2.3 Definitions of Markets Covered in the Report

3 Cardiovascular Monitoring Devices Market, United States

3.1 Cardiovascular Monitoring Devices Market, United States, Revenue ($m), 2018-2033

3.1.1 Holter Monitors Market, United States, Revenue ($m), by Segment, 2018-2033

3.2 Cardiovascular Monitoring Devices Market, United States, Volume (Units), 2018-2033

3.2.1 Holter Monitors Market, United States, Volume (Units), by Segment, 2018-2033

3.3 Cardiovascular Monitoring Devices Market, United States, Average Price ($), 2018-2033

3.4 Cardiovascular Monitoring Devices Market, United States, Company Share by Revenue ($m), 2024

4 Overview of Key Companies in United States, Cardiovascular Monitoring Devices Market

4.1 Koninklijke Philips NV

4.1.1 Company Overview

4.2 Boston Scientific Corp

4.2.1 Company Overview

4.3 GE HealthCare Technologies Inc

4.3.1 Company Overview

4.4 Contec Medical Systems Co Ltd

4.4.1 Company Overview

4.5 Hill-Rom Holdings Inc

4.5.1 Company Overview

4.6 Suzuken Co Ltd

4.6.1 Company Overview

4.7 Shenzhen Mindray Bio-Medical Electronics Co Ltd

4.7.1 Company Overview

5 Cardiovascular Monitoring Devices Market Pipeline Products

6 Recent Developments

6.1 Corporate Communications

6.1.1 Nov 13, 2025: Cleveland Clinic Pitch Competition Awards $100,000 Grant to AutoCMR Inventors

6.1.2 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization

6.1.3 Oct 30, 2025: Edwards Lifesciences CFO Transition Plan Announced

6.1.4 Oct 29, 2025: Sparrow BioAcoustics Secures $10 Million for U.S. Deployment of Smartphone-Based Cardiac AI

6.1.5 Oct 21, 2025: Burl Concepts Closes Oversubscribed $4.5 Million Investment

6.1.6 Sep 29, 2025: Bridge to Life Appoints David Castiglioni as Chief Commercial Officer

6.1.7 Sep 29, 2025: Sparrow BioAcoustics Joins Innovators' Network at American Heart Association

6.1.8 Sep 10, 2025: UMaine Opens Labs to SMCC Students for Biomedical Engineering Research

6.1.9 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed

6.1.10 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio

6.1.11 Feb 25, 2025: CONMED Corp Adds Mark Kaye to its Board of Directors

6.1.12 Jan 13, 2025: Vaso Corp Announces Executive Leadership Appointments & Names New Vice Chairman to the Board of Directors

6.2 Financial Announcements

6.2.1 Nov 13, 2025: HeartBeam Reports Third Quarter 2025 Results

6.2.2 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results

6.2.3 Nov 06, 2025: Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook

6.2.4 Oct 23, 2025: Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025

6.2.5 Oct 03, 2025: Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025

6.2.6 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results

6.2.7 Jul 31, 2025: iRhythm Technologies Announces Second Quarter 2025 Financial Results

6.2.8 Jul 18, 2025: Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025

6.2.9 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

6.2.10 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

6.2.11 Apr 24, 2025: ICU Medical Announces Time of First Quarter 2025 Earnings Conference Call

6.2.12 Apr 17, 2025: GE HealthCare to Announce First Quarter 2025 Results on April 30, 2025

6.2.13 Feb 27, 2025: ICU Medical Announces Fourth Quarter 2024 Results and Provides Fiscal Year 2025 Guidance

6.2.14 Feb 13, 2025: Teleflex Announces Fourth Quarter 2024 Earnings Conference Call Information

6.2.15 Feb 04, 2025: Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025

6.2.16 Dec 12, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2024 Results on February 13, 2025

6.3 Government and Public Interest

6.3.1 Nov 17, 2025: GE HealthCare Management to Present at Upcoming Investor Conference

6.3.2 Nov 11, 2025: iRhythm Technologies Publishes Large-Scale Study in Heart Rhythm and Presents New Data at AHA Scientific Sessions 2025

6.3.3 Nov 03, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule

6.3.4 Aug 21, 2025: ICU Medical to Participate in Upcoming Investor Conferences

6.3.5 Aug 21, 2025: GE HealthCare Management to Present at Upcoming Investor Conferences

6.3.6 Aug 20, 2025: iRhythm Technologies to Participate in Upcoming Investor Conferences

6.3.7 May 01, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule

6.3.8 Apr 24, 2025: Mabwell To Present Clinical Data of 9mw2821 Combined With Toripalimab in Patients With UC in an Oral Presentation at 2025 ASCO

6.3.9 Feb 10, 2025: GE Healthcare Management to Present at Upcoming Investor Conference

6.4 Legal And Regulatory

6.4.1 Oct 17, 2025: Acarix Responds to G-BA Decision on Reimbursement in the German Market

6.4.2 Oct 09, 2025: Covidien Receives Additional 510(K) Clearance For Shiley Oral/ Nasal Reinforced Endotracheal Tube

6.5 Other Significant Developments

6.5.1 Nov 17, 2025: Inmedix CloudHRV System Surpasses 1000 Procedures in Its First 5 Months

6.5.2 Nov 13, 2025: HeartBeam Reports Third Quarter 2025 Results

6.5.3 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results

6.5.4 Nov 13, 2025: Cleveland Clinic Pitch Competition Awards $100,000 Grant to AutoCMR Inventors

6.5.5 Nov 11, 2025: iRhythm Technologies Publishes Large-Scale Study in Heart Rhythm and Presents New Data at AHA Scientific Sessions 2025

6.5.6 Oct 29, 2025: Sparrow BioAcoustics Secures $10 Million for U.S. Deployment of Smartphone-Based Cardiac AI

6.5.7 Oct 17, 2025: Acarix Responds to G-BA Decision on Reimbursement in the German Market

6.5.8 Sep 30, 2025: Novarad Installs NovaCardio with EncaptureMD Structured Reporting at Capitol Medical Center

6.5.9 Sep 11, 2025: ESC Congress 2025 Confirms Superior Predictive Value of Caristo FAI-Score™ Technology for Cardiac Death

6.5.10 Jun 02, 2025: Successful Q1 for Medicalgorithmics.Service revenue in the U.S. up 329% YoY. 11 new contracts in the first five months of

2025.

6.5.11 Apr 01, 2025: Axsome Therapeutics Announces Topline Results of PARADIGM Phase 3 Proof-of-Concept Trial of Solriamfetol in MDD with and without EDS

6.5.12 Dec 04, 2024: DocGo Inks Contract in Mississippi With Major Hospital System to Provide Adult and Pediatric Remote Cardiac Monitoring Services

6.6 Product News

6.6.1 Nov 20, 2025: Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Clinical Results

6.6.2 Nov 17, 2025: Inmedix CloudHRV System Surpasses 1000 Procedures in Its First 5 Months

6.6.3 Nov 13, 2025: HeartBeam Reports Third Quarter 2025 Results

6.6.4 Nov 11, 2025: iRhythm Technologies Publishes Large-Scale Study in Heart Rhythm and Presents New Data at AHA Scientific Sessions 2025

6.6.5 Nov 11, 2025: iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at Aha Scientific Sessions 2025

6.6.6 Nov 06, 2025: Agitated Solutions Enrolls First Patient in Phase 3 'Enhance' Trial of Novel Contrast Agent for Cardiac Bubble Studies

6.6.7 Nov 05, 2025: Fluid Control Solutions For MedTech

6.6.8 Nov 04, 2025: AVS Reports Positive Safety and Effectiveness Data from Pulse IVL IDE Study

6.6.9 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization

6.6.10 Oct 26, 2025: Real-World Data Presented at TCT 2025 Shows EggNest Complete Radiation Protection System Reduces Radiation Exposure for Cath Lab Team

6.6.11 Oct 24, 2025: Terumo Interventional Systems Announces FDA Clearance for OPUSWAVE Dual Sensor Imaging System and DualView Imaging Catheter

6.6.12 Oct 22, 2025: Norav Medical Launches TeleEVENT – Full Disclosure Event Recorder for Remote Cardiac Telemetry

6.6.13 Oct 21, 2025: SpectraWAVE Receives 510(k) Clearance for X1-FFR, an AI-Enabled, Wire-Free, Drug-Free Physiology Solution

6.6.14 Oct 21, 2025: Burl Concepts Closes Oversubscribed $4.5 Million Investment

6.6.15 Oct 17, 2025: Midmark Digital ECG Now Offers DICOM Compatibility

6.6.16 Oct 09, 2025: Asahi Kasei Achieves FDA Approval for ZOLL’s Zenix Monitor/Defibrillator

6.6.17 Oct 01, 2025: Adagio Medical Completes Enrollment in FULCRUM-VT Clinical Trial for Ventricular Tachycardia

6.6.18 Sep 30, 2025: Novarad Installs NovaCardio with EncaptureMD Structured Reporting at Capitol Medical Center

6.6.19 Sep 30, 2025: Relief Cardiovascular Announces First-In-Human Procedures With Transcatheter Smart Implant for Heart Failure Treatment

6.6.20 Sep 29, 2025: Bridge to Life Appoints David Castiglioni as Chief Commercial Officer

6.6.21 Sep 29, 2025: Sparrow BioAcoustics Joins Innovators' Network at American Heart Association

6.6.22 Sep 29, 2025: iHeartMedia and OSO Studios Launch Cardiac Cowboys Podcast Narrated by Chris Pine

6.6.23 Sep 28, 2025: Aminomethylbenzoic Acid Injection – Letter to Medical Staff

6.6.24 Sep 28, 2025: Acoramidis Reduces Cardiovascular Outcomes in ATTR-CM Patients Within the First Month

6.6.25 Sep 25, 2025: FDA Clears EFAST Algorithm for Cardiovascular AI

6.6.26 Sep 18, 2025: Argá Medtech Announces First Enrollments in COHERENT-AF Clinical Trial

6.6.27 Sep 17, 2025: AI Outperforms Doctors In Predicting Surgical Complications

6.6.28 Sep 11, 2025: ESC Congress 2025 Confirms Superior Predictive Value of Caristo FAI-Score™ Technology for Cardiac Death

6.6.29 Sep 11, 2025: Tricorder Study Proves AI Enhances Heart Disease Detection

6.6.30 Sep 09, 2025: HeartBeam Reports Study Showing Comparable Accuracy Between HeartBeam System and Standard 12-Lead ECG

6.6.31 Apr 02, 2025: Scientists Unveil Starfish-Inspired Wearable Tech for Heart Monitoring

6.6.32 Mar 24, 2025: ICU Medical To Present at the 24th Annual Needham Virtual Healthcare Conference

6.6.33 Dec 04, 2024: Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in U.S. To Use Fda-Approved Mapping and Dual Energy Ablation Catheter

6.7 Strategy And Business Planning

6.7.1 Nov 13, 2025: HeartBeam Reports Third Quarter 2025 Results

6.7.2 Nov 11, 2025: iRhythm Technologies Publishes Large-Scale Study in Heart Rhythm and Presents New Data at AHA Scientific Sessions 2025

6.7.3 Nov 05, 2025: Microbot Medical Commences Limited Market Release of LIBERTY Endovascular Robotic System in the U.S.

6.7.4 Nov 05, 2025: JLL Partners Announces Combination of Vascular Technology Incorporated and Parks Medical Electronics

6.7.5 Oct 28, 2025: HeartBeam Partners With HeartNexus for 24/7 Remote Cardiology Services

6.7.6 Oct 07, 2025: Physiotika Announces Partnership With IonOptix in France

6.7.7 Sep 26, 2025: Philips and Optum to expand cardiac monitoring services in US

6.7.8 Sep 25, 2025: Philips Joins Optum Healthcare Network as Preferred Provider

6.7.9 Sep 18, 2025: Argá Medtech Announces First Enrollments in COHERENT-AF Clinical Trial

6.7.10 Sep 11, 2025: Tricorder Study Proves AI Enhances Heart Disease Detection

6.7.11 Sep 10, 2025: UMaine Opens Labs to SMCC Students for Biomedical Engineering Research

6.7.12 Jul 31, 2025: iRhythm Technologies Announces Strategic Partnership With Lucem Health

7 Appendix

7.1 Research Methodology

7.1.1 Coverage

7.1.2 Secondary Research

7.1.3 Primary Research

7.1.4 Market Modeling and Forecasting

7.1.5 Company Share Analysis

7.1.6 Benchmarking

7.2 GlobalData Consulting

7.3 Contact Us

7.4 Disclaimer

Table

Table 1: Cardiovascular Monitoring Devices Market, United States, Revenue ($m), USD Constant, 2018-2033

Table 2: Holter Monitors Market, United States, Revenue ($m), USD Constant, 2018-2033

Table 3: Cardiovascular Monitoring Devices Market, United States, Volume (Units), 2018-2033

Table 4: Holter Monitors Market, United States, Volume (Units), 2018-2033

Table 5: Cardiovascular Monitoring Devices Market, United States, Average Price ($), 2018-2033

Table 6: Cardiovascular Monitoring Devices Market, United States, Company Share by Revenue ($m), 2024

Table 7: Cardiovascular Monitoring Devices Market Pipeline Products

Figures

Figure 1: Cardiovascular Monitoring Devices Market, United States, Revenue ($m), USD Constant, 2018-2033

Figure 2: Holter Monitors Market, United States, Revenue ($m), USD Constant, 2018-2033

Figure 3: Cardiovascular Monitoring Devices Market, United States, Volume (Units), 2018-2033

Figure 4: Holter Monitors Market, United States, Volume (Units), 2018-2033

Figure 5: Cardiovascular Monitoring Devices Market, United States, Company Share (%), 2024

United States Cardiovascular Monitoring Devices Market Outlook to 2033 – Resting ECG Machines and Holter Monitors standard reports
Currency USD
$4,995

Can be used by individual purchaser only

$14,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States Cardiovascular Monitoring Devices Market Outlook to 2033 – Resting ECG Machines and Holter Monitors in real time.

  • Access a live United States Cardiovascular Monitoring Devices Market Outlook to 2033 – Resting ECG Machines and Holter Monitors dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.